Logo image of MNOW.CA

MEDNOW INC-A (MNOW.CA) Stock Fundamental Analysis

TSX-V:MNOW - TSX Venture Exchange - CA58503L2021 - Common Stock - Currency: CAD

0.02  -0.04 (-63.64%)

Fundamental Rating

0

Taking everything into account, MNOW scores 0 out of 10 in our fundamental rating. MNOW was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of MNOW have multiple concerns. MNOW has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MNOW had negative earnings in the past year.
In the past year MNOW has reported a negative cash flow from operations.
MNOW had negative earnings in each of the past 5 years.
In the past 5 years MNOW always reported negative operating cash flow.
MNOW.CA Yearly Net Income VS EBIT VS OCF VS FCFMNOW.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 -5M -10M -15M -20M -25M

1.2 Ratios

Industry RankSector Rank
ROA -195.36%
ROE N/A
ROIC N/A
ROA(3y)-65.76%
ROA(5y)-2284.76%
ROE(3y)-173.67%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MNOW.CA Yearly ROA, ROE, ROICMNOW.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 -2K -4K -6K -8K -10K

1.3 Margins

The Profit Margin and Operating Margin are not available for MNOW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MNOW.CA Yearly Profit, Operating, Gross MarginsMNOW.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 -500 -1K -1.5K -2K

More info and screens

0

2. Health

2.1 Basic Checks

MNOW does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MNOW remains at a similar level compared to 1 year ago.
MNOW has a worse debt/assets ratio than last year.
MNOW.CA Yearly Shares OutstandingMNOW.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 5M 10M 15M 20M
MNOW.CA Yearly Total Debt VS Total AssetsMNOW.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -6.08, we must say that MNOW is in the distress zone and has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.08
ROIC/WACCN/A
WACC4.05%
MNOW.CA Yearly LT Debt VS Equity VS FCFMNOW.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 10M -10M 20M 30M

2.3 Liquidity

MNOW has a Current Ratio of 0.41. This is a bad value and indicates that MNOW is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.32 indicates that MNOW may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.41
Quick Ratio 0.32
MNOW.CA Yearly Current Assets VS Current LiabilitesMNOW.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for MNOW have decreased by -1.69% in the last year.
MNOW shows a strong growth in Revenue. In the last year, the Revenue has grown by 1100.55%.
EPS 1Y (TTM)-1.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.37%
Revenue 1Y (TTM)1100.55%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%466.23%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MNOW.CA Yearly Revenue VS EstimatesMNOW.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MNOW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MNOW.CA Price Earnings VS Forward Price EarningsMNOW.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MNOW.CA Per share dataMNOW.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MNOW!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEDNOW INC-A

TSX-V:MNOW (11/2/2023, 7:00:00 PM)

0.02

-0.04 (-63.64%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap297.29K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.28
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.11
FCFYN/A
OCF(TTM)-0.96
OCFYN/A
SpS2.37
BVpS-0.13
TBVpS-0.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -195.36%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.18%
FCFM N/A
ROA(3y)-65.76%
ROA(5y)-2284.76%
ROE(3y)-173.67%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.48
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 81.26%
Cap/Sales 6.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.41
Quick Ratio 0.32
Altman-Z -6.08
F-Score3
WACC4.05%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.37%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1100.55%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%466.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-611.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-626.99%
OCF growth 3YN/A
OCF growth 5YN/A